	Single-cell and spatial omics of metabolic-immune ecosystems in prostate cancer: from androgen signaling to therapy resistance. Front Immunol Wang R, Li Y, Wang X. PMID: 42626336 [PubMed - indexed for MEDLINE]
	Updated oncolytic viruses for the treatment of bladder cancer: a systematic review. Iran J Microbiol Khatami F, Mohammadi A, Azadmanesh K, Deyhimfar R, Ghajar HA, Nikoofar P, Aghamir SMK. PMID: 42625927 [PubMed]
	The Impact of Chronic Kidney Disease on Postoperative Outcomes in Patients With Bladder Cancer: A Meta-Analysis. Clin Med Insights Oncol Shi Y, Luo X, Huang Y, Tan C, Liu J. PMID: 42625803 [PubMed]
	Multimodal deep learning for prediction of postoperative recurrence in clear cell renal cell carcinoma: a clinical-radiologic-pathologic approach. Front Oncol Yang Y, Wu J, Shi F, Ren Q, Gao P, Meng X. PMID: 42625638 [PubMed]
	Comparative outcomes of robot-assisted and open radical nephrectomy with inferior vena cava thrombectomy for renal cell carcinoma: a systematic review and meta-analysis. J Robot Surg Ma XD, Chen SY, Yang JW, Wang L, Dong ZL, Yang L. PMID: 42624966 [PubMed - indexed for MEDLINE]
	Re: Contieri R, Paciotti M, Uleri A, et al. Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe Trial. Eur Urol Oncol. 2026;9:404-412. Eur Urol Oncol Scarpa RM. PMID: 42624768 [PubMed - as supplied by publisher]
	PSMA PET Imaging for Prostate Cancer Recurrence After Minimally Invasive Focal Therapy: A Single-Center Retrospective Study. J Nucl Med Jafarvand M, Farolfi A, Mei R, Djaileb L, Benz M, Chung A, Brisbane W, Marks L, Grogan T, Gafita A, Theus L, Nguyen AT, Czernin J, Calais J. PMID: 42624652 [PubMed - as supplied by publisher]
	The emerging trends in prostate cancer treatment: a systematic review of the literature. J Chemother Fatima SA, Haider KH, Qutubuddin S, Begum Y, Stevenson M, Fatima K, Anwar EI, Barg M. PMID: 42624527 [PubMed - as supplied by publisher]
	Immunophenotyping and Molecular Patterns of Prostate Cancer in East Africa: Diagnostic and Prognostic Implications-A Systematic Review. Clin Genitourin Cancer Posite CM, Wabinga H, Atwine R, Vahwere BM, Mitamo AA, Hakizimana T, Kiswezi A, Archibong VB, Usman IM. PMID: 42624022 [PubMed - as supplied by publisher]
	Best evidence summary for non-pharmacological management of cancer-related fatigue in patients with prostate cancer. Geriatr Nurs Jiang M, Xu M, Chen Q, Fu X, Lin X, Chen X. PMID: 42623906 [PubMed - as supplied by publisher]
	Could the preoperative urethral curve be used to predict immediate urinary continence following Retzius-sparing robot-assisted radical prostatectomy? A retrospective multi-center study. Int Braz J Urol Lin BH, Chen Y, Ke ZB, Wang CH, Chen YH, Yan XL, Liu JZ, Fan JJ, Xu QJ, Zhuang SB, Zhu ZH, Chen SH, Zheng QS, Xue XY, Zhuang JL, Wei Y, Xu N. PMID: 42623599 [PubMed - indexed for MEDLINE]
	Beyond Surgical Technique: Evolving Strategies to Reduce Urinary Incontinence After Radical Prostatectomy. Curr Urol Rep Londono AP, Yellu A, Hanes R, Wallace BK, George AK, Lokeshwar SD. PMID: 42622969 [PubMed - indexed for MEDLINE]
	Ultrahypofractionated linac-based radiotherapy of primary prostate cancer - early results of an Austrian nationwide registry study. Clin Transl Radiat Oncol Annon-Eberharter N, Berchtold J, Ginestet A, Gruber G, Kocik L, Komina O, Langsenlehner T, Nechvile E, Resl C, Röder F, Vorbach SM, Zahlbruckner L, Wolf F. PMID: 42621857 [PubMed]
	Stereotactic radiotherapy for rib metastases from prostate cancer: A multicenter real-world analysis of local control, pain response, and treatment tolerance (RIBRISK). Ther Adv Med Oncol Bilski M, Mastroleo F, Banaszek I, Korab K, Ku, J, Peszy, Ponikowska J, Fijuth J, Jereczek Fossa BA, Zilli T, Kotecha R, Siva S, Guckenberger M, Kishan A, Kuncman . PMID: 42621202 [PubMed]
	Renal Cell Carcinoma Texture Analysis With the KiTS23 Dataset: A Retrospective Study. Adv Urol Liang Y, Campbell AG, Bhattacharjee S. PMID: 42620935 [PubMed]
	Efficacy and safety of [(161)Tb]Tb-PSMA radioligand therapy in metastatic castration resistant prostate cancer: a systematic review and meta-analysis. Front Med (Lausanne) Albano D, Paone G, Treglia G. PMID: 42620854 [PubMed]
	Efficacy and Safety of Enfortumab Vedotin by Trial Eligibility in Advanced Urothelial Carcinoma: A Multicenter Real-World Study. Int J Urol Wakita N, Hara T, Tobe T, Ueki H, Suzuki K, Terakawa T, Teishima J, Miyake H. PMID: 42619566 [PubMed - indexed for MEDLINE]
	Factors Influencing Postoperative Urinary Incontinence in Prostate Cancer Patients: A Retrospective Cohort Study. Am J Nurs Liu L, Wu L, Gu S. PMID: 42619203 [PubMed - indexed for MEDLINE]
	Optimal prostate-specific antigen thresholds for early salvage therapy after robotic-assisted radical prostatectomy. Urol Oncol Lee JH, Lee CU, Song W, Kang M, Sung HH, Jeon HG, Jeong BC, Seo SI, Jeon SS. PMID: 42618170 [PubMed - indexed for MEDLINE]
	Cotinine enhances androgen receptor stability and promotes androgen-dependent proliferation in prostate cancer cells: An in vitro study. Arch Biochem Biophys Hayashi R, Kudo Y, Yoshino Y, Shiota M, Fujimoto N, Ikari A, Endo S. PMID: 42617929 [PubMed - as supplied by publisher]

Articles 1 - 20 / 180871

Page 1 of 9044



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy